Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics

Area of Science:

• Cardiology
• Regenerative Medicine
• Cell Therapy

Background:

• Cardiovascular diseases (CVDs) are a major global health challenge requiring novel treatments.
• Mesenchymal stem cells (MSCs) show promise for cardiovascular repair, but challenges remain in optimizing their therapeutic potential.
• Evolution of cell-based therapies has progressed from foundational approaches to advanced strategies.

Purpose of the Study:

• To review the historical development and current state of MSC-based cardiovascular therapeutics.
• To explore innovative strategies in the fourth generation of cell-based therapies for cardiovascular regeneration.
• To highlight advancements in refining MSCs' pro-regenerative capacity and ensuring therapeutic efficacy.

Main Methods:

• Review of historical and current research on MSCs in cardiovascular disease.
• Analysis of fourth-generation cell-based therapy strategies.
• Discussion of secretomics, extracellular vesicles, scaffolds, 3D propagation, genetic modification, and GMP protocols.

Main Results:

• MSCs have evolved as a key therapeutic for cardiovascular diseases.
• Fourth-generation strategies enhance MSC potential through secretomics, biomaterials, advanced culture, genetic engineering, and GMP.
• These advancements aim to improve safety, efficacy, and patient-specific treatments for cardiovascular regeneration.

Conclusions:

• MSCs are pivotal in advancing cardiovascular therapeutics.
• Future cardiovascular regeneration will be significantly shaped by these innovative MSC-based strategies.
• Continued research and refinement of MSC therapies promise a new era in treating cardiovascular diseases.